Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

AMN Healthcare Services, Inc.

AMNNYSE
Wall Street Score · overall investment41/100
$46.72USD$-0.09 (-0.19%)
Company website www.amnhealthcare.com
Headquarters2999 Olympus Boulevard, Dallas, TX, 75019, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Care Facilities
Price from Oct 29, 2026Financials updated Oct 1, 2026

AMN · Price history

Price at last available close

$46.72

+$11.77 (+33.68%) 1M

2026-10-28

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About AMN Healthcare Services, Inc.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions.

How they make money

AMN Healthcare provides comprehensive healthcare workforce solutions and staffing services to hospitals and health systems. The company generates revenue primarily through long-term managed services contracts and temporary staffing placements, where clients pay for the talent solutions and technology platforms provided to address clinical and leadership labor shortages.

Products & services

The company provides nurse and allied staffing, physician and leadership placement, and healthcare technology solutions including vendor management systems and workforce optimization software.

Brands & revenue mix

No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

Customer concentration

The company discloses that hospital concentration and managed services contracts mean revenues from some larger health systems have grown and may continue to grow, as noted in the 2025 Annual Report.

Suppliers, materials & equipment

  • Healthcare Professionals — Individual clinicians and healthcare leaders who provide services to AMN clients.Source

Strengths

  • Large-scale provider of clinical workforce management solutionsSource
  • Full suite of workforce solutions and technology platformsSource

Risks

  • Concentration of buyers of healthcare staffing servicesSource
  • Dependence on the permanent labor market and healthcare staffing demandSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

41

Weak

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

58

Fair

Financial Strength

68

Business Quality / Moat

39

Management

79

Growth Quality

66

Risk / Durability

22

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

27

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

35/100

Building Historical Record

Model Score 35/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Balance-sheet / debt profile scores strongly
  • •Recent buyback activity is present
What to watch
  • •Debt service risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Asset quality is a weaker factor

Company-specific research

Questions worth answering for AMN

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can AMN maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is AMN's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is AMN's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify AMN's current valuation?
Debt service risk
Business analysis: 16 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

41

0–100 · Weak

Opportunity Score

27

0–100 · Poor

Market Cap

$1.81B

P/E Ratio

13.3

EPS

$2.70

52-Week High

$37.22

52-Week Low

$14.97

Beta

0.39

Intrinsic Value

$22.95

Analyst Target

$38.00

Shares Outstanding

38.5M

Total Revenue

$3.43B

Total Debt

$775.8M

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$19.24

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
99/ 100
+3 pts / 5d

Strong upward momentum

5D +8.6% · 20D +30.2% · RSI 85 · Price vs 20D avg +15.6%
Volatility
37/ 100
+13 pts / 5d

Normal movement

20D realized vol 45.8% · 60D 54.0% · Acceleration 0.85x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for AMN

Detected from reported data — verify before acting.

Dividend history reported

Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Debt service risk

Interest coverage is low (~0.7x). Earnings may be strained to cover interest expense.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on AMN.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Large-scale provider of clinical workforce management solutions.
  • +Full suite of workforce solutions and technology platforms.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
  • −Concentration of buyers of healthcare staffing services.
  • −Dependence on the permanent labor market and healthcare staffing demand.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak41/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Weak

41

Tap for breakdown →

Strong

86

Debt Cost5.7%
Debt Reduction YoY26.8%
Debt / Equity1.25x

Tap for breakdown →

Weak

47

Revenue YoY25.8%
Revenue CAGR-15.1%
Net Margin3.1%

Tap for breakdown →

Weak

49

Asset Growth YoY-13.3%
Liquidation/Share$19.24
Net Assets/MCap1.14x

Tap for breakdown →

Strong

73

Earnings Yield7.5%
Buyback Yield18.0%
Debt Cost5.7%

Tap for breakdown →

Strong

79

ROIC2.9%
ROE14.2%
ROA4.4%

Tap for breakdown →

Poor

39

EPS Growth—
FCF/Share Growth2.6%
Rev/Share Growth-0.3%

Tap for breakdown →

Poor

26

Intrinsic Value$22.95
Value Reference$13.77
MOS-103.6%

Tap for breakdown →

Fair

59

Revenue47
Moat39
Valuation26

Tap for breakdown →

Poor

0

MOS %-103.6%
Value Reference$13.77
Deep Discount Reference$9.18

Tap for breakdown →

Poor

16

Interest Coverage0.7x
ROIC2.9%
FCF Yield16.8%

Tap for breakdown →

Poor

34

Financial16
Valuation26
Debt86

Tap for breakdown →

Poor

29

Survival Years0.2 yrs
Current Ratio0.94x
FCF Margin8.6%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

5 historical score records available

Previous Score

42

Sep 8, 2026

Change

-0.4

points

Current Score

41

Oct 1, 2026

Category Changes

Revenue-0.4
Debt0
Assets-1.2
Capital-3.0
Management0
Moat0
Valuation0
Buffett-0.2

AMN decreased 0.4 points because Capital declined by 3 points.

Negative Contributors

  • − Capital declined by 3 points

Projected Score

Projected Score

40

Projected Change

-1.4 points

Preliminary comparable-period financial changes suggest decline of approximately 1.4 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$46.72

Model Intrinsic Value

$22.95

Difference

+$23.77

+103.6% vs IV

Margin of Safety

-103.6%

UndervaluedFair ValueOvervalued
Value Reference: $13.77
Deep Discount Reference: $9.18

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$1.5B$3.0B$4.5B$6.0B

Additional Metrics

Operating Cash Flow

201520172019202120232025$0$200M$400M$600M$800M

Total Debt

201520172019202120232025$0$350M$700M$1.1B$1.4B

Total Assets

201520172019202120232025$0$800M$1.6B$2.4B$3.2B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$3.43B$2.73B$2.98B$3.79B····························
Cost of Revenue$2.48B$1.96B$2.06B$2.54B····························
Gross Profit$954.3M$774.1M$919.4M$1.25B····························
Research & Development$0.00$0.00$0.00$0.00····························
SG&A Expenses$656.5M$593.0M$632.5M$756.2M····························
Operating Expenses$793.6M$740.9M$1.02B$911.2M····························
EBITDA$343.9M$101.1M$71.1M$499.4M····························
Operating Income$160.7M$33.2M-$102.7M$338.4M····························
Interest Expense$35.6M$45.6M$69.9M$54.1M····························
Income Before Tax$164.2M-$101.1M-$172.6M$284.3M····························
Income Tax Expense$59.3M-$5.4M-$25.6M$73.6M····························
Net Income$104.9M-$95.7M-$147.0M$210.7M····························
Basic EPS$2.70$-2.48$-3.85$5.38····························
Basic Shares39.02M38.52M38.19M39.17M····························
Diluted Shares39.73M38.52M38.19M39.34M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:Nov 5, 2026
Estimated EPS: $0.23Estimated revenue: $648.9M
Jun 30, 2026Q2FY2026

Revenue

$673.2M

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.53

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

-18.8%

Cash Change

+771.8%

Margin Change

+20.8 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded
  • Cash position grew
  • Debt reduced

Potential Score Impact

Positive indicators included revenue growth, cash levels, debt levels, net income margin. Pressure indicators included EPS growth. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 2.3%. EPS declined 117.5%. Cash increased 771.8%. Total debt declined 18.8%. Net income margin improved by 20.8 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 120 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

40

Smart Money

40

Number of Gurus

1

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Log in to view dividend history.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

5 historical records
Jul 19, 26Aug 11, 26Sep 1, 26Sep 8, 26Oct 1, 260255075100

Historical Score Chart

3 of 5 records shown
3 historical score records are shown. Start your seven-day free trial to unlock 2 more records and the complete score history.Start Free Trial

Wall Street Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Debt Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Revenue Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Asset Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Capital Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Management Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Moat Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Valuation Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Buffett Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Intrinsic Value

Sep 1, 26Sep 8, 26Oct 1, 26$20.00$21.00$22.00$23.00$24.00

Value Reference

Sep 1, 26Sep 8, 26Oct 1, 26$11.00$12.00$13.00$14.00$15.00

Margin of Safety %

Sep 1, 26Sep 8, 26Oct 1, 26-0.6%-0.5%-0.5%-0.5%-0.5%

Related Companies

Medical - Care Facilities

UHS

Universal Health Services, Inc.

72Strong
$186.89View

SRTA

Strata Critical Medical, Inc.

63Fair
$4.81View

NUTX

Nutex Health, Inc.

62Fair
$209.30View

ADUS

Addus HomeCare Corporation

59Fair
$118.03View

THC

Tenet Healthcare Corporation

57Fair
$268.50View

AVAH

Aveanna Healthcare Holdings Inc.

56Fair
$12.75View

News

Rumor Mill · AMN

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial